These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8200940)

  • 1. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.
    Rivkees SA; el-Hajj-Fuleihan G; Brown EM; Crawford JD
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum parathyroid hormone in X-linked hypophosphatemia.
    Arnaud C; Glorieux F; Scriver C
    Science; 1971 Aug; 173(3999):845-7. PubMed ID: 5315247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets.
    Bettinelli A; Bianchi ML; Mazzucchi E; Gandolini G; Appiani AC
    J Pediatr; 1991 Mar; 118(3):372-6. PubMed ID: 1847972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
    Roof BS; Piel CF; Gordan GS
    Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
    [No Abstract]   [Full Text] [Related]  

  • 7. "Tertiary" hyperparathyroidism and apparent "cure" of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx.
    Olefsky J; Kempson R; Jones H; Reaven G
    N Engl J Med; 1972 Apr; 286(14):740-5. PubMed ID: 4337228
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.
    Alon US; Levy-Olomucki R; Moore WV; Stubbs J; Liu S; Quarles LD
    Clin J Am Soc Nephrol; 2008 May; 3(3):658-64. PubMed ID: 18256372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
    Seikaly MG; Quigley R; Baum M
    Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-existence of X-linked hypophosphatemic rickets (XLH) and primary hyperparathyroidism: case report and review of the literature.
    Tournis ST; Giannikou PV; Paspati IN; Katsalira EA; Voskaki IC; Lyritis GP
    J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):150-4. PubMed ID: 15951631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets.
    Mäkitie O; Kooh SW; Sochett E
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):163-8. PubMed ID: 12580931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets.
    Kruse K
    J Pediatr; 1995 May; 126(5 Pt 1):736-41. PubMed ID: 7751997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.
    Short E; Morris RC; Sebastian A; Spencer M
    J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The loss of circadian rhythm for intact parathyroid hormone and nephrogenous cyclic AMP in patients with primary hyperparathyroidism.
    Logue FC; Fraser WD; Gallacher SJ; Cameron DA; O'Reilly DS; Beastall GH; Patel U; Boyle IT
    Clin Endocrinol (Oxf); 1990 Apr; 32(4):475-83. PubMed ID: 2161300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U; Chan JC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM; Lee PD; Morris AH; Reiter EO; Gertner JM; Marcus R; Quarmby VE; Rosenfeld RG
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
    Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
    J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperparathyroidism in patients with X-linked dominant hypophosphatemic rickets--application of the calcium infusion test as an indicator for parathyroidectomy.
    Alon U; Newsome H; Chan JC
    Int J Pediatr Nephrol; 1984 Mar; 5(1):39-43. PubMed ID: 6609135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.